TetraLogic Pharmaceuticals' IPO

TetraLogic Pharmaceuticals raised a round of funding on December 12, 2013. Investors include Public.

TetraLogic Pharmaceuticals is focused on the discovery and development of drugs to treat cancer through technology which allows drugs to be developed that unblock the cell death or apoptosis pathway, …

Articles about TetraLogic Pharmaceuticals' IPO: